Immobilization stress may increase plasma lnterleukin-6 via central and peripheral catecholamines

Atsushi Takaki, Qin Heng Huang, Aniko Somogyvári-Vigh, Akira Arimura

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

It has recently been reported that both physical and psychological stress elevate plasma interleukin (IL)-6 levels independently of endotoxemia. tissue damage, or inflammation. However. the mechanism of plasma IL-6 elevation in these models is poorly understood. In the present study, plasma IL-6 levels were measured using the lL-6-dependent murine hybrido- ma subclonc B9 cell line, which is commonly used by other investigators. We first demonstrated that an immobilization (IM) stress, a typical physicopsvchological stress, increased plasma IL-6 levels. Then the contribution of the hypothalamic-pituitary-adrenal (HPA) axis and the central and peripheral catecholamincrgic systems in IM-induced plasma IL-6 elevation were examined because these mechanisms play important roles in host defense against stress. Blood samples were collected through an indwelling jugular venous catheter before, during, and after 1M: The number of samples taken serially from each animal was 12-13. Blood cells were resuspendcd in a saline solution and injected into the animals through the same catheter after each blood collection in order to prevent loss of blood volume. After initiation of restraint, plasma IL-6 levels significantly increased at 60 min and peaked at 90 min in the animals immobilized for cither 30 or 120 min. The peak levels of IM-induced plasma IL-6 in the animals immobilized for 120 min (1,905 ± 414 U/ml) were significantly higher than those in the animals subjected to 30 min IM (837 ± 95 U/ml; p < 0.05). In the hypophysectomized (Hypox) or adrcnalectomizcd (ADX) rats, the peak levels of IM-induced (60 min) plasma IL-6 were considerably higher than in sham-operated rats (Hypox: 33.281 ± 4.983 U/ml at 150 min; ADX: 52.020 ± 19.231 U/ml at 120 min). In addition, in order to determine the possible involvement of endogenous catecholamines in IM-induced plasma IL-6 elevation. 6-hydroxydopamine (6-OHDA) was injected into the lateral cerebral vcntricle (i.cv., 100 ng/rat) or jugular vein (i.v. 100 mg/kg) of the rats, and the animals were exposed to IM stress I week (i.cv.) or 3 days (i.v.) after injection. Both i.cv. and i.v. injections of 6- OHDA markedly attenuated the plasma IL-6 response to IM as compared to the respective vehicle-injected group, whereas the plasma adrenocorticotropic hormone response to IM stress was reduced only by pretreatment with an i.cv. injection of 6-OHDA. These data suggest that (1) neither the pituitary nor the adrenal gland is a major source of increased plasma IL-6 induced by IM stress; (2) the HPA axis exhibits a suppressive regulatory role in the IM-induced IL-6 response: (3) both the central and peripheral catecholamines play critical roles in causing IL-6 elevation induced by IM stress, and (4) the involvement of peripheral catccholamines in elevating plasma IL-6 by IM stress is independent of HPA axis activation. Moreover, to determine whether splenocytes arc the source of IM-induced plasma IL-6, splc- ncctomized (Splex) rats were examined for their plasma IL-6 response to IM stress. The peak IL-6 levels after IM in Splex animals were significantly higher than those in sham-operated animals (p < 0.05). The immune-competent cells in the spleen, as well as the pituitary and adrenal glands do not seem to be a source of the increased levels of plasma IL-6 induced by IM stress.

Original languageEnglish
Pages (from-to)335-342
Number of pages8
JournalNeuroImmunoModulation
Volume1
Issue number6
DOIs
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

Immobilization
Catecholamines
Interleukin-6
Oxidopamine
Adrenal Glands
Injections
Catheters
Endotoxemia
Jugular Veins
Hybridomas
Pituitary Gland
Blood Volume
Psychological Stress
Sodium Chloride
Adrenocorticotropic Hormone

All Science Journal Classification (ASJC) codes

  • Immunology
  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems

Cite this

Immobilization stress may increase plasma lnterleukin-6 via central and peripheral catecholamines. / Takaki, Atsushi; Huang, Qin Heng; Somogyvári-Vigh, Aniko; Arimura, Akira.

In: NeuroImmunoModulation, Vol. 1, No. 6, 01.01.1994, p. 335-342.

Research output: Contribution to journalArticle

Takaki, Atsushi ; Huang, Qin Heng ; Somogyvári-Vigh, Aniko ; Arimura, Akira. / Immobilization stress may increase plasma lnterleukin-6 via central and peripheral catecholamines. In: NeuroImmunoModulation. 1994 ; Vol. 1, No. 6. pp. 335-342.
@article{692d63f4f6184b708c3a4a1a31297352,
title = "Immobilization stress may increase plasma lnterleukin-6 via central and peripheral catecholamines",
abstract = "It has recently been reported that both physical and psychological stress elevate plasma interleukin (IL)-6 levels independently of endotoxemia. tissue damage, or inflammation. However. the mechanism of plasma IL-6 elevation in these models is poorly understood. In the present study, plasma IL-6 levels were measured using the lL-6-dependent murine hybrido- ma subclonc B9 cell line, which is commonly used by other investigators. We first demonstrated that an immobilization (IM) stress, a typical physicopsvchological stress, increased plasma IL-6 levels. Then the contribution of the hypothalamic-pituitary-adrenal (HPA) axis and the central and peripheral catecholamincrgic systems in IM-induced plasma IL-6 elevation were examined because these mechanisms play important roles in host defense against stress. Blood samples were collected through an indwelling jugular venous catheter before, during, and after 1M: The number of samples taken serially from each animal was 12-13. Blood cells were resuspendcd in a saline solution and injected into the animals through the same catheter after each blood collection in order to prevent loss of blood volume. After initiation of restraint, plasma IL-6 levels significantly increased at 60 min and peaked at 90 min in the animals immobilized for cither 30 or 120 min. The peak levels of IM-induced plasma IL-6 in the animals immobilized for 120 min (1,905 ± 414 U/ml) were significantly higher than those in the animals subjected to 30 min IM (837 ± 95 U/ml; p < 0.05). In the hypophysectomized (Hypox) or adrcnalectomizcd (ADX) rats, the peak levels of IM-induced (60 min) plasma IL-6 were considerably higher than in sham-operated rats (Hypox: 33.281 ± 4.983 U/ml at 150 min; ADX: 52.020 ± 19.231 U/ml at 120 min). In addition, in order to determine the possible involvement of endogenous catecholamines in IM-induced plasma IL-6 elevation. 6-hydroxydopamine (6-OHDA) was injected into the lateral cerebral vcntricle (i.cv., 100 ng/rat) or jugular vein (i.v. 100 mg/kg) of the rats, and the animals were exposed to IM stress I week (i.cv.) or 3 days (i.v.) after injection. Both i.cv. and i.v. injections of 6- OHDA markedly attenuated the plasma IL-6 response to IM as compared to the respective vehicle-injected group, whereas the plasma adrenocorticotropic hormone response to IM stress was reduced only by pretreatment with an i.cv. injection of 6-OHDA. These data suggest that (1) neither the pituitary nor the adrenal gland is a major source of increased plasma IL-6 induced by IM stress; (2) the HPA axis exhibits a suppressive regulatory role in the IM-induced IL-6 response: (3) both the central and peripheral catecholamines play critical roles in causing IL-6 elevation induced by IM stress, and (4) the involvement of peripheral catccholamines in elevating plasma IL-6 by IM stress is independent of HPA axis activation. Moreover, to determine whether splenocytes arc the source of IM-induced plasma IL-6, splc- ncctomized (Splex) rats were examined for their plasma IL-6 response to IM stress. The peak IL-6 levels after IM in Splex animals were significantly higher than those in sham-operated animals (p < 0.05). The immune-competent cells in the spleen, as well as the pituitary and adrenal glands do not seem to be a source of the increased levels of plasma IL-6 induced by IM stress.",
author = "Atsushi Takaki and Huang, {Qin Heng} and Aniko Somogyv{\'a}ri-Vigh and Akira Arimura",
year = "1994",
month = "1",
day = "1",
doi = "10.1159/000097185",
language = "English",
volume = "1",
pages = "335--342",
journal = "NeuroImmunoModulation",
issn = "1021-7401",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Immobilization stress may increase plasma lnterleukin-6 via central and peripheral catecholamines

AU - Takaki, Atsushi

AU - Huang, Qin Heng

AU - Somogyvári-Vigh, Aniko

AU - Arimura, Akira

PY - 1994/1/1

Y1 - 1994/1/1

N2 - It has recently been reported that both physical and psychological stress elevate plasma interleukin (IL)-6 levels independently of endotoxemia. tissue damage, or inflammation. However. the mechanism of plasma IL-6 elevation in these models is poorly understood. In the present study, plasma IL-6 levels were measured using the lL-6-dependent murine hybrido- ma subclonc B9 cell line, which is commonly used by other investigators. We first demonstrated that an immobilization (IM) stress, a typical physicopsvchological stress, increased plasma IL-6 levels. Then the contribution of the hypothalamic-pituitary-adrenal (HPA) axis and the central and peripheral catecholamincrgic systems in IM-induced plasma IL-6 elevation were examined because these mechanisms play important roles in host defense against stress. Blood samples were collected through an indwelling jugular venous catheter before, during, and after 1M: The number of samples taken serially from each animal was 12-13. Blood cells were resuspendcd in a saline solution and injected into the animals through the same catheter after each blood collection in order to prevent loss of blood volume. After initiation of restraint, plasma IL-6 levels significantly increased at 60 min and peaked at 90 min in the animals immobilized for cither 30 or 120 min. The peak levels of IM-induced plasma IL-6 in the animals immobilized for 120 min (1,905 ± 414 U/ml) were significantly higher than those in the animals subjected to 30 min IM (837 ± 95 U/ml; p < 0.05). In the hypophysectomized (Hypox) or adrcnalectomizcd (ADX) rats, the peak levels of IM-induced (60 min) plasma IL-6 were considerably higher than in sham-operated rats (Hypox: 33.281 ± 4.983 U/ml at 150 min; ADX: 52.020 ± 19.231 U/ml at 120 min). In addition, in order to determine the possible involvement of endogenous catecholamines in IM-induced plasma IL-6 elevation. 6-hydroxydopamine (6-OHDA) was injected into the lateral cerebral vcntricle (i.cv., 100 ng/rat) or jugular vein (i.v. 100 mg/kg) of the rats, and the animals were exposed to IM stress I week (i.cv.) or 3 days (i.v.) after injection. Both i.cv. and i.v. injections of 6- OHDA markedly attenuated the plasma IL-6 response to IM as compared to the respective vehicle-injected group, whereas the plasma adrenocorticotropic hormone response to IM stress was reduced only by pretreatment with an i.cv. injection of 6-OHDA. These data suggest that (1) neither the pituitary nor the adrenal gland is a major source of increased plasma IL-6 induced by IM stress; (2) the HPA axis exhibits a suppressive regulatory role in the IM-induced IL-6 response: (3) both the central and peripheral catecholamines play critical roles in causing IL-6 elevation induced by IM stress, and (4) the involvement of peripheral catccholamines in elevating plasma IL-6 by IM stress is independent of HPA axis activation. Moreover, to determine whether splenocytes arc the source of IM-induced plasma IL-6, splc- ncctomized (Splex) rats were examined for their plasma IL-6 response to IM stress. The peak IL-6 levels after IM in Splex animals were significantly higher than those in sham-operated animals (p < 0.05). The immune-competent cells in the spleen, as well as the pituitary and adrenal glands do not seem to be a source of the increased levels of plasma IL-6 induced by IM stress.

AB - It has recently been reported that both physical and psychological stress elevate plasma interleukin (IL)-6 levels independently of endotoxemia. tissue damage, or inflammation. However. the mechanism of plasma IL-6 elevation in these models is poorly understood. In the present study, plasma IL-6 levels were measured using the lL-6-dependent murine hybrido- ma subclonc B9 cell line, which is commonly used by other investigators. We first demonstrated that an immobilization (IM) stress, a typical physicopsvchological stress, increased plasma IL-6 levels. Then the contribution of the hypothalamic-pituitary-adrenal (HPA) axis and the central and peripheral catecholamincrgic systems in IM-induced plasma IL-6 elevation were examined because these mechanisms play important roles in host defense against stress. Blood samples were collected through an indwelling jugular venous catheter before, during, and after 1M: The number of samples taken serially from each animal was 12-13. Blood cells were resuspendcd in a saline solution and injected into the animals through the same catheter after each blood collection in order to prevent loss of blood volume. After initiation of restraint, plasma IL-6 levels significantly increased at 60 min and peaked at 90 min in the animals immobilized for cither 30 or 120 min. The peak levels of IM-induced plasma IL-6 in the animals immobilized for 120 min (1,905 ± 414 U/ml) were significantly higher than those in the animals subjected to 30 min IM (837 ± 95 U/ml; p < 0.05). In the hypophysectomized (Hypox) or adrcnalectomizcd (ADX) rats, the peak levels of IM-induced (60 min) plasma IL-6 were considerably higher than in sham-operated rats (Hypox: 33.281 ± 4.983 U/ml at 150 min; ADX: 52.020 ± 19.231 U/ml at 120 min). In addition, in order to determine the possible involvement of endogenous catecholamines in IM-induced plasma IL-6 elevation. 6-hydroxydopamine (6-OHDA) was injected into the lateral cerebral vcntricle (i.cv., 100 ng/rat) or jugular vein (i.v. 100 mg/kg) of the rats, and the animals were exposed to IM stress I week (i.cv.) or 3 days (i.v.) after injection. Both i.cv. and i.v. injections of 6- OHDA markedly attenuated the plasma IL-6 response to IM as compared to the respective vehicle-injected group, whereas the plasma adrenocorticotropic hormone response to IM stress was reduced only by pretreatment with an i.cv. injection of 6-OHDA. These data suggest that (1) neither the pituitary nor the adrenal gland is a major source of increased plasma IL-6 induced by IM stress; (2) the HPA axis exhibits a suppressive regulatory role in the IM-induced IL-6 response: (3) both the central and peripheral catecholamines play critical roles in causing IL-6 elevation induced by IM stress, and (4) the involvement of peripheral catccholamines in elevating plasma IL-6 by IM stress is independent of HPA axis activation. Moreover, to determine whether splenocytes arc the source of IM-induced plasma IL-6, splc- ncctomized (Splex) rats were examined for their plasma IL-6 response to IM stress. The peak IL-6 levels after IM in Splex animals were significantly higher than those in sham-operated animals (p < 0.05). The immune-competent cells in the spleen, as well as the pituitary and adrenal glands do not seem to be a source of the increased levels of plasma IL-6 induced by IM stress.

UR - http://www.scopus.com/inward/record.url?scp=0028543542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028543542&partnerID=8YFLogxK

U2 - 10.1159/000097185

DO - 10.1159/000097185

M3 - Article

VL - 1

SP - 335

EP - 342

JO - NeuroImmunoModulation

JF - NeuroImmunoModulation

SN - 1021-7401

IS - 6

ER -